Your browser doesn't support javascript.
loading
Evaluation of Susceptibility Testing Methods for Aztreonam and Ceftazidime-Avibactam Combination Therapy on Extensively Drug-Resistant Gram-Negative Organisms.
Khan, Ayesha; Erickson, Samuel G; Pettaway, Cedric; Arias, Cesar A; Miller, William R; Bhatti, Micah M.
Afiliação
  • Khan A; Center for Antimicrobial Resistance and Microbial Genomics, Division of Infectious Diseases, UTHealth, McGovern Medical School, UTHealth, Houston, Texas, USA.
  • Erickson SG; Center for Antimicrobial Resistance and Microbial Genomics, Division of Infectious Diseases, UTHealth, McGovern Medical School, UTHealth, Houston, Texas, USA.
  • Pettaway C; Center for Antimicrobial Resistance and Microbial Genomics, Division of Infectious Diseases, UTHealth, McGovern Medical School, UTHealth, Houston, Texas, USA.
  • Arias CA; Center for Antimicrobial Resistance and Microbial Genomics, Division of Infectious Diseases, UTHealth, McGovern Medical School, UTHealth, Houston, Texas, USA.
  • Miller WR; Center for Infectious Diseases, UTHealth School of Public Health, Houston, Texas, USA.
  • Bhatti MM; Center for Antimicrobial Resistance and Microbial Genomics, Division of Infectious Diseases, UTHealth, McGovern Medical School, UTHealth, Houston, Texas, USA.
Antimicrob Agents Chemother ; 65(11): e0084621, 2021 10 18.
Article em En | MEDLINE | ID: mdl-34424044

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Aztreonam / Antibacterianos Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Aztreonam / Antibacterianos Idioma: En Ano de publicação: 2021 Tipo de documento: Article